| Literature DB >> 35264669 |
Gergely Losonczy1, Peter Piko2, B Jeroen Klevering1, Zsigmond Kosa3, Janos Sandor4, Roza Adany5,6.
Abstract
The Roma population is the largest transnational ethnic minority group in Europe, often facing socioeconomic inequalities and various health problems. In the present study, we investigated visual acuity and its influencing factors along with spectacle use of the Roma population in comparison with the general population in Hungary. A cross-sectional survey was carried out including 832 participants aged 20-64 years. We recorded the uncorrected visual acuity along with anthropometric, demographic, socioeconomic and health-related data of each individual. Although the average uncorrected visual acuity was somewhat higher, the use of a visual aid was significantly less frequent in the Roma population, especially in the group with a visual acuity below 0.5 in both eyes (14.3% vs. 77.1%, p < 0.001). Age, abdominal obesity and disturbances of carbohydrate metabolism had a negative impact on visual acuity in both populations; however, the latter was a much stronger risk factor in the Roma population (OR 5.789, 95% CI 2.239-14.964, p < 0.001) than in the general population (OR 2.075, 95% CI 1.097-3.926, p = 0.025). Our results show serious unmet health needs within the Roma population, which calls for public health programs to improve poor primary care indicators on regular eye examination and much more rigorous diabetes control.Entities:
Mesh:
Year: 2022 PMID: 35264669 PMCID: PMC8907268 DOI: 10.1038/s41598-022-07880-3
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Main characteristics of the Hungarian general (HG) and Roma (HR) populations by sex.
| Male | Female | |||||
|---|---|---|---|---|---|---|
| HG | HR | HG | HR | |||
| (n = 178) | (n = 71) | (n = 218) | (n = 239) | |||
| Prevalence (n) | Prevalence (n) | |||||
| 20–34 years | 22.5% (40) | 23.9% (17) | 0.343 | 28.0% (61) | 31.0% (74) | 0.041 |
| 35–49 years | 44.4% (79) | 35.2% (25) | 33.5% (73) | 41.4% (99) | ||
| 50–64 years | 33.1% (59) | 40.8% (29) | 38.5% (84) | 27.6% (66) | ||
| Not completed primary school | 3.4% (6) | 19.7% (14) | < 0.001 | 1.8% (4) | 23.0% (55) | < 0.001 |
| Completed primary school | 16.4% (29) | 63.4% (45) | 21.6% (47) | 62.8% (150) | ||
| Completed secondary school | 63.3% (112) | 16.9% (12) | 57.8% (126) | 13.0% (31) | ||
| Higher education | 16.9% (30) | 0.0% (0) | 18.3% (40) | 0.4% (1) | ||
| N/A | 0.6% (1) | 0.0% (0) | 0.5% (1) | 0.8% (2) | ||
Average uncorrected visual acuity (A) and the prevalence of severely decreased visual acuity (defined as UCVA < 0.5) (B) in the Hungarian general and Roma populations by sex.
| A | Male | Female | ||||
|---|---|---|---|---|---|---|
| HG | HR | HG | HR | |||
| Average (95%CI) | Average (95%CI) | |||||
| Left eye | 0.93 (0.87–0.98) | 1.14 (1.04–1.24) | 0.001 | 0.91 (0.86–0.96) | 1.01 (0.96–1.07) | 0.004 |
| Right eye | 0.94 (0.88–0.99) | 1.08 (0.98–1.19) | 0.052 | 0.91 (0.86–0.96) | 1.00 (0.95–1.06) | 0.011 |
| All eyes | 0.93 (0.88–0.99) | 1.11 (1.02–1.21) | 0.009 | 0.91 (0.86–0.96) | 1.01 (0.95–1.06) | 0.012 |
Frequency of people using glasses or contact lenses in the Hungarian general (HG) and Roma (HR) populations by age group (A) and representation of individuals using glasses or contact lenses with uncorrected visual acuity of ≥ 0.5 vs. < 0.5 in the Hungarian general (HG) and Roma (HR) populations (B).
| HG | HR | ||
|---|---|---|---|
| Prevalence (n) | |||
| 20–34 years | 22.8% (23) | 4.4% (4) | < 0.001 |
| 35–49 years | 17.8% (27) | 5.6% (7) | 0.002 |
| 50–64 years | 31.5% (45) | 18.9% (18) | 0.032 |
| Both eyes ≥ 0.5 | 15.9% (55) | 8.4% (23) | 0.006 |
| One eye < 0.5 | 92.9% (13) | 18.8% (3) | < 0.001 |
| Both eyes < 0.5 | 77.1% (27) | 14.3% (3) | < 0.001 |
The correlation obtained by linear regression analysis between visual acuity (average visual acuity for both eyes, left and right eyes as a continuous outcome variable) and cardiometabolic risk factors/outcomes as components of metabolic syndrome, as well as demographic characteristics on combined (A), Hungarian general (B) and Roma (C) populations.
| Average of left and right eyes | Left eye | Right eye | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Beta | 95% CI | Beta | 95% CI | Beta (95% CI) | 95% CI | ||||
| Age | − 0.006 | − 0.009 to − 0.004 | < 0.001 | − 0.006 | − 0.008 to − 0.003 | < 0.001 | − 0.006 | − 0.008 to − 0.003 | < 0.001 |
| Roma ethnicity* | 0.092 | 0.027 to 0.157 | 0.006 | 0.110 | 0.044 to 0.176 | 0.001 | 0.079 | 0.013 to 0.146 | 0.019 |
| Female sex* | − 0.039 | − 0.100 to 0.022 | 0.210 | − 0.048 | − 0.109 to 0.014 | 0.128 | − 0.034 | − 0.096 to 0.028 | 0.283 |
| Education level* | 0.005 | − 0.028 to 0.037 | 0.784 | 0.002 | − 0.031 to 0.035 | 0.900 | 0.005 | − 0.028 to 0.039 | 0.751 |
| Abdominal obesity* | − 0.100 | − 0.168 to − 0.033 | 0.003 | − 0.098 | − 0.166 to − 0.030 | 0.005 | − 0.101 | − 0.169 to − 0.032 | 0.004 |
| Reduced HDL-C level* | 0.025 | − 0.035 to 0.085 | 0.411 | 0.027 | − 0.034 to 0.088 | 0.381 | 0.029 | − 0.032 to 0.090 | 0.355 |
| Elevated TG level and/or lipid-lowering treatment* | 0.039 | − 0.024 to 0.101 | 0.225 | 0.034 | − 0.030 to 0.097 | 0.299 | 0.042 | − 0.022 to 0.106 | 0.197 |
| Elevated fasting glucose level and/or anti-diabetic treatment* | − 0.142 | − 0.208 to − 0.076 | < 0.001 | − 0.148 | − 0.214 to − 0.081 | < 0.001 | − 0.134 | − 0.201 to − 0.067 | < 0.001 |
| Elevated blood pressure and/or anti-hypertensive treatment* | 0.039 | − 0.022 to 0.099 | 0.207 | 0.036 | − 0.025 to 0.097 | 0.251 | 0.031 | − 0.031 to 0.092 | 0.329 |
| Age | − 0.004 | − 0.007 to − 0.001 | 0.010 | − 0.004 | − 0.007 to − 0.001 | 0.016 | − 0.003 | − 0.006 to − 0.001 | 0.024 |
| Female sex* | 0.001 | − 0.072 to 0.073 | 0.988 | − 0.002 | − 0.074 to 0.071 | 0.967 | − 0.007 | − 0.079 to 0.064 | 0.843 |
| Education level* | 0.026 | − 0.017 to 0.068 | 0.232 | 0.023 | − 0.019 to 0.066 | 0.281 | 0.029 | − 0.013 to 0.071 | 0.173 |
| Abdominal obesity* | − 0.110 | − 0.195 to − 0.025 | 0.011 | − 0.106 | − 0.192 to − 0.021 | 0.015 | − 0.109 | − 0.193 to − 0.025 | 0.011 |
| Reduced HDL-C level* | 0.039 | − 0.039 to 0.117 | 0.322 | 0.040 | − 0.038 to 0.119 | 0.313 | 0.037 | − 0.040 to 0.114 | 0.348 |
| Elevated TG level and/or lipid-lowering treatment* | 0.014 | − 0.065 to 0.092 | 0.729 | 0.003 | − 0.076 to 0.082 | 0.939 | 0.020 | − 0.058 to 0.097 | 0.619 |
| Elevated fasting glucose level and/or anti-diabetic treatment* | − 0.098 | − 0.180 to − 0.015 | 0.021 | − 0.100 | − 0.184 to − 0.017 | 0.019 | − 0.088 | − 0.170 to − 0.006 | 0.036 |
| Elevated blood pressure and/or anti-hypertensive treatment * | 0.049 | − 0.026 to 0.123 | 0.202 | 0.045 | − 0.030 to 0.120 | 0.243 | 0.048 | − 0.026 to 0.122 | 0.207 |
| Age | − 0.011 | − 0.015 to − 0.006 | < 0.001 | − 0.010 | − 0.014 to − 0.006 | < 0.001 | − 0.010 | − 0.015 to − 0.006 | < 0.001 |
| Female sex* | − 0.131 | − 0.239 to − 0.023 | 0.018 | − 0.151 | − 0.261 to − 0.041 | 0.007 | − 0.101 | − 0.214 to 0.012 | 0.080 |
| Education level* | − 0.031 | − 0.082 to 0.020 | 0.228 | − 0.033 | − 0.085 to 0.018 | 0.206 | − 0.033 | − 0.087 to 0.020 | 0.219 |
| Abdominal obesity* | − 0.066 | − 0.175 to 0.043 | 0.234 | − 0.066 | − 0.177 to 0.045 | 0.241 | − 0.070 | − 0.185 to 0.044 | 0.225 |
| Reduced HDL-C level* | 0.003 | − 0.091 to 0.096 | 0.957 | 0.007 | − 0.088 to 0.103 | 0.879 | 0.011 | − 0.087 to 0.109 | 0.832 |
| Elevated TG level and/or lipid-lowering treatment* | 0.070 | − 0.033 to 0.173 | 0.185 | 0.071 | − 0.034 to 0.175 | 0.185 | 0.074 | − 0.033 to 0.182 | 0.176 |
| Elevated fasting glucose level and/or anti-diabetic treatment* | − 0.220 | − 0.326 to − 0.113 | < 0.001 | − 0.230 | − 0.338 to − 0.122 | < 0.001 | − 0.211 | − 0.323 to − 0.099 | < 0.001 |
| Elevated blood pressure and/or anti-hypertensive treatment* | 0.056 | − 0.047 to 0.158 | 0.185 | 0.052 | − 0.052 to 0.15 | 0.324 | 0.037 | − 0.071 to 0.144 | 0.502 |
*Binary covariate.
The correlation obtained by logistic regression analysis between severe visual impairment (visual acuity for both eyes less than 0.5) and cardiometabolic risk factors/outcomes as components of metabolic syndrome, as well as demographic characteristics in combined (A), Hungarian general (B) and Roma (C) populations.
| Less than 0.5 for both eyes | |||
|---|---|---|---|
| OR | 95% CI | ||
| Age | 1.031 | 1.007–1.055 | 0.011 |
| Roma ethnicity* | 0.860 | 0.484–1.528 | 0.606 |
| Female sex* | 1.372 | 0.800–2.355 | 0.250 |
| Education level* | 1.210 | 0.935–1.565 | 0.147 |
| Abdominal obesity* | 1.334 | 0.692–2.571 | 0.389 |
| Reduced HDL-C level* | 0.605 | 0.347–1.055 | 0.077 |
| Elevated TG level and/or lipid-lowering treatment* | 0.842 | 0.488–1.452 | 0.537 |
| Elevated fasting glucose level and/or anti-diabetic treatment* | 2.760 | 1.646–4.626 | < 0.001 |
| Elevated blood pressure and/or anti-hypertensive treatment | 1.166 | 0.664–2.048 | 0.593 |
| Age | 1.022 | 0.995–1.050 | 0.111 |
| Female sex* | 1.007 | 0.542–1.870 | 0.983 |
| Education level* | 1.047 | 0.725–1.511 | 0.806 |
| Abdominal obesity* | 1.253 | 0.576–2.726 | 0.570 |
| Reduced HDL-C level* | 0.502 | 0.242–1.040 | 0.064 |
| Elevated TG level and/or lipid-lowering treatment* | 1.170 | 0.609–2.251 | 0.637 |
| Elevated fasting glucose level and/or anti-diabetic treatment* | 2.075 | 1.097–3.926 | 0.025 |
| Elevated blood pressure and/or anti-hypertensive treatment* | 1.075 | 0.556–2.076 | 0.831 |
| Age | 1.064 | 1.015–1.116 | 0.010 |
| Female sex* | 5.369 | 1.283–22.462 | 0.021 |
| Education level* | 1.434 | 0.999–2.059 | 0.051 |
| Abdominal obesity* | 1.130 | 0.312–4.096 | 0.853 |
| Reduced HDL-C level* | 0.768 | 0.297–1.987 | 0.586 |
| Elevated TG level and/or lipid-lowering treatment* | 0.438 | 0.154–1.246 | 0.122 |
| Elevated fasting glucose level and/or anti-diabetic treatment* | 5.789 | 2.239–14.964 | < 0.001 |
| Elevated blood pressure and/or anti-hypertensive treatment* | 1.332 | 0.441–4.021 | 0.611 |
*Binary covariate.
The association of covariates with Roma ethnicity on visual acuity as a ≥ 0.5 vs. < 0.5 in both eyes categorical outcome variable in the interaction model.
| Interaction with Roma ethnicity | |||
|---|---|---|---|
| OR | 95% CI | ||
| Age | 1.006 | 0.997–1.016 | 0.204 |
| Female sex* | 1.101 | 0.875–1.384 | 0.412 |
| Education level* | 1.093 | 0.938–1.275 | 0.255 |
| Abdominal obesity* | 1.129 | 0.771–1.652 | 0.533 |
| Reduced HDL-C level* | 0.750 | 0.531–1.058 | 0.101 |
| Elevated TG level and/or lipid-lowering treatment* | 0.828 | 0.576–1.189 | 0.307 |
| Elevated fasting glucose level and/or anti-diabetic treatment* | 1.950 | 1.395–2.726 | < 0.001 |
| Elevated blood pressure and/or anti-hypertensive treatment* | 1.082 | 0.767–1.526 | 0.654 |
*Binary covariate.